ArticleCancer medicine2020
PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma.
Pusen Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it